LGALS13 antibody (AA 23-134) (Biotin)

Catalog No. ABIN6189413

Product Details anti-LGALS13 Antibody (Biotin)

Target: LGALS13 (Lectin, Galactoside-Binding, Soluble, 13 (LGALS13))

Binding Specificity: AA 23-134

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This LGALS13 antibody is conjugated to Biotin

Application: Flow Cytometry (FACS), Immunofluorescence (IF), Immunohistochemistry (IHC), Western Blotting (WB)

Purpose: Mouse Monoclonal anti-Galectin-13 / Placental-Protein-13 (PP13/1161), Biotin Conjugate

Characteristics: This antibody recognizes a 32 kDa protein, which is identified as homodimer of galectin-13 (also known as PP13). Galectins are a family of soluble ?-galactoside-binding lectins that modulate cell-to-cell adhesion and cell-to-extracellular matrix (ECM) interactions and play a role in tumor progression, pre-mRNA splicing and apoptosis. One such member, galectin-13, is a 139 amino acid protein that contains one galectin domain. Possessing lysophospholipase activity, galectin-13 exists as a disulfide-linked homodimer. Galectin-13 is suggested to have a developmental role in the placenta and may display immunobiological activity in feto-maternal blood-spaces. Screening for galectin-13 in maternal serum during the first trimester of pregnancy may serve as a diagnostic marker to predict preterm pre-eclampsia. Primary antibodies are available purified, or with a selection of fluorescent CF® dyes and other labels. CF® dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

Immunogen: Recombinant human Galectin-13 protein fragment (aa23-134) (exact sequence is proprietary)

Clone: PP13-1161

Isotype: IgG2b kappa

Application Details

Application Notes: Immunohistology (formalin) 0.5-1 μg/mL

• Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM Tris, 1 mM EDTA  pH 9.0 or 10 mM citrate buffer  pH 6.0 for 10-20 min followed by cooling at RT for 20 min
• Immunofluorescence 0.5-1 μg/mL
• Flow Cytometry 0.5-1 μg/million cells/0.1 mL
• Western blotting 0.5-1 μg/mL
• Optimal dilution for a specific application should be determined by user

Comment:

K-562 cells. Placenta or Spleen.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 100 μg/mL

Buffer: PBS/0.1 % BSA/0.05 % azide

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Target Details for LGALS13

Target: LGALS13 (Lectin, Galactoside-Binding, Soluble, 13 (LGALS13))

Alternative Name: Galectin-13 / Placental-Protein-13 (LGALS13 Products)

Synonyms: GAL13 antibody, PLAC8 antibody, PP13 antibody, Gal-11 antibody, Gal-13 antibody, Gal11 antibody, gal-13 antibody, galectin 13 antibody, avian beta-defensin 13 antibody, LGALS13 antibody, AvBD13 antibody

Background: Gal-13, GAL13, Galactoside-binding soluble lectin 13, Galectin-13, Galectin13, Lectin galactoside binding soluble 13, LGALS13, PLAC8, Placental protein 13 (PP13), Placental tissue protein 13

Molecular Weight: 16 kDa (monomer), 32 kDa (homodimer)

Gene ID: 29124, 23671

UniProt: Q9UHV8